AIIMS Chief Says Decision To Administer Remdesivir Must Be Taken By Medical Professional
- byDoctor News Daily Team
- 02 August, 2025
- 0 Comments
- 0 Mins
New Delhi: AIIMS Delhi Director Dr Randeep Guleria said on Friday that the decision to administer Remdesivir must be taken by a medical professional and it should be administered only in a hospital setting.
Dr Guleria, who was addressing a joint media briefing, said a COVID-19 patient under home isolation will stand discharged and end isolation after at least 10 days have passed from the onset of symptoms and there is no fever for three days. "There is no need for testing after the home isolation period is over," he said.
Also Read:PIL seeks GST exemption for Remdesivir, Tocilizumab, Favipiravir, other COVID drugs, medical equipment
"The decision to administer Remdesivir must be taken by a medical professional and administered only in a hospital setting," he added.
A Health Ministry official said that Karnataka, Kerala, West Bengal, Tamil Nadu, Goa, and Odisha are not only reporting higher peaks but also high case growth trajectory of COVID-19 cases.
He said Health Ministry is closely coordinating with states regarding the availability and supply of medical oxygen- 8,593 MT has been allocated to 23 states.
The official said that states are also advised to undertake oxygen consumption audit in all hospitals including private hospitals.
India is seeing an unprecedented surge in COVID-19 cases in the second wave of pandemic.
Also Read: Appropriate use of Remdesivir - know this better
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
AIIMS Delhi doctors told to use Hindi in prescript...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!